z-logo
open-access-imgOpen Access
Avapritinib: preclinical studies of a promising novel therapeutic option for gastrointestinal stromal tumors
Author(s) -
Milena Urbini
Publication year - 2019
Publication title -
gastrointestinal stromal tumor
Language(s) - English
Resource type - Journals
ISSN - 2663-1911
DOI - 10.21037/gist.2019.01.03
Subject(s) - pdgfra , gastrointestinal tract , gist , malignancy , tyrosine kinase inhibitor , stromal cell , mesenchymal stem cell , tyrosine kinase , receptor tyrosine kinase , cancer research , medicine , targeted therapy , proto oncogene proteins c kit , sunitinib , stromal tumor , imatinib , oncology , bioinformatics , pathology , biology , receptor , cancer , stem cell , myeloid leukemia , haematopoiesis , stem cell factor , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom